Bornem Pharma SRL
2.4 FTEBornem Pharma reported total assets of €1.27m at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Aug 2026), with 2.4 full-time equivalents.
The score of Bornem Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +39 % Total assets +21 % Headcount (avg FTE) +20 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bornem Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 247,989 € | ||||
| Equity | 303,310 € | ||||
| Cash | 434,852 € | ||||
| EBITDA | 288,641 € | ||||
| Total assets | €1.27m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Aug 2026
- Year ended 31 Dec 2024filed on 01 Aug 2025
- Year ended 31 Dec 2023filed on 15 Aug 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 16 Aug 2022
Bornem Pharma's financial analysis
- Solvency23.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bornem Pharma
Bornem Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0465.495.476
- VAT number
- BE0465495476
- Peppol
- Registered · 0208:0465495476 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Mar 1999
- Registered office
- 2880 Bornem
- Size
- Micro · 2.4 FTE
- Latest accounts
- 2025 · filed on 06 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Bornem Pharma (SRL) has been based in Bornem since 1999, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 247,989 € and equity of 303,310 €; its revenue is not published. With 2.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 23.9%, below the median of its sector (44.2%).
Companies similar to Bornem Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Claeys-Buyle Retail sale of pharmaceutical products Geraardsbergen · balance sheet €1.27m
- Apoteek Van Elewyck - Sint Hubertus Retail sale of pharmaceutical products Hasselt · balance sheet €1.27m
- Pharmacie Duchene-Colinet Retail sale of pharmaceutical products Dalhem · balance sheet €1.27m
- Pharma Hesbaye Retail sale of pharmaceutical products Liège · balance sheet €1.27m
- Pharmayou Waremme Gare Retail sale of pharmaceutical products Waremme · balance sheet €1.28m
- Angophar Retail sale of pharmaceutical products Brussels · balance sheet €1.26m
- Oostveld - Pharma Retail sale of pharmaceutical products Lievegem · balance sheet €1.26m
- Farmajes Retail sale of pharmaceutical products Antwerp · balance sheet €1.28m
Frequently asked questions about Bornem Pharma
What is the revenue of Bornem Pharma?
Bornem Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bornem Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0465495476 for Bornem Pharma, if the company is VAT-registered. Its company number (CBE) is 0465.495.476.
Where is the registered office of Bornem Pharma?
According to the CBE register, the registered office of Bornem Pharma is in 2880 Bornem.
What is the equity of Bornem Pharma?
At the close of the 2025 financial year, the equity of Bornem Pharma amounts to 303,310 €, a solvency of 23.9% of total assets.
How many people work at Bornem Pharma?
2.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Bornem Pharma?
The register lists 2 active mandates at Bornem Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bornem Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →